294 related articles for article (PubMed ID: 27975100)
1. Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus.
Fejes Z; Póliska S; Czimmerer Z; Káplár M; Penyige A; Gál Szabó G; Beke Debreceni I; Kunapuli SP; Kappelmayer J; Nagy B
Thromb Haemost; 2017 Feb; 117(3):529-542. PubMed ID: 27975100
[TBL] [Abstract][Full Text] [Related]
2. Reduced miR-26b Expression in Megakaryocytes and Platelets Contributes to Elevated Level of Platelet Activation Status in Sepsis.
Szilágyi B; Fejes Z; Póliska S; Pócsi M; Czimmerer Z; Patsalos A; Fenyvesi F; Rusznyák Á; Nagy G; Kerekes G; Berhés M; Szűcs I; Kunapuli SP; Kappelmayer J; Nagy B
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013235
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients.
Yang S; Zhao J; Chen Y; Lei M
Cardiovasc Toxicol; 2016 Jul; 16(3):213-22. PubMed ID: 26175178
[TBL] [Abstract][Full Text] [Related]
4. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.
Elgheznawy A; Shi L; Hu J; Wittig I; Laban H; Pircher J; Mann A; Provost P; Randriamboavonjy V; Fleming I
Circ Res; 2015 Jul; 117(2):157-65. PubMed ID: 25944670
[TBL] [Abstract][Full Text] [Related]
5. Effects of endurance training on hsa-miR-223, P2RY12 receptor expression and platelet function in type 2 diabetic patients.
Taghizadeh M; Ahmadizad S; Naderi M
Clin Hemorheol Microcirc; 2018; 68(4):391-399. PubMed ID: 29526844
[TBL] [Abstract][Full Text] [Related]
6. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review.
Pordzik J; Jakubik D; Jarosz-Popek J; Wicik Z; Eyileten C; De Rosa S; Indolfi C; Siller-Matula JM; Czajka P; Postula M
Cardiovasc Diabetol; 2019 Aug; 18(1):113. PubMed ID: 31470851
[TBL] [Abstract][Full Text] [Related]
7. Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets.
Rowley JW; Chappaz S; Corduan A; Chong MM; Campbell R; Khoury A; Manne BK; Wurtzel JG; Michael JV; Goldfinger LE; Mumaw MM; Nieman MT; Kile BT; Provost P; Weyrich AS
Blood; 2016 Apr; 127(14):1743-51. PubMed ID: 26773046
[TBL] [Abstract][Full Text] [Related]
8. Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment.
La Rosa G; Biasucci LM; Mandolini C; Massimi I; Copponi G; Pulcinelli FM; Crea F
J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):611-613. PubMed ID: 30015780
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.
Luo M; Li R; Deng X; Ren M; Chen N; Zeng M; Yan K; Xia J; Liu F; Ma W; Yang Y; Wan Q; Wu J
Acta Diabetol; 2015 Oct; 52(5):943-9. PubMed ID: 25820527
[TBL] [Abstract][Full Text] [Related]
10. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
Randriamboavonjy V; Pistrosch F; Bölck B; Schwinger RH; Dixit M; Badenhoop K; Cohen RA; Busse R; Fleming I
Circulation; 2008 Jan; 117(1):52-60. PubMed ID: 18071073
[TBL] [Abstract][Full Text] [Related]
11. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.
Stratz C; Nührenberg T; Fiebich BL; Amann M; Kumar A; Binder H; Hoffmann I; Valina C; Hochholzer W; Trenk D; Neumann FJ
Thromb Haemost; 2014 May; 111(5):902-11. PubMed ID: 24352417
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-reduced miR-27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti-angiogenic thrombospondin-1.
Miao X; Rahman MF; Jiang L; Min Y; Tan S; Xie H; Lee L; Wang M; Malmström RE; Lui WO; Li N
J Thromb Haemost; 2018 Apr; 16(4):791-801. PubMed ID: 29442415
[TBL] [Abstract][Full Text] [Related]
13. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease.
de Boer HC; van Solingen C; Prins J; Duijs JM; Huisman MV; Rabelink TJ; van Zonneveld AJ
Eur Heart J; 2013 Nov; 34(44):3451-7. PubMed ID: 23386708
[TBL] [Abstract][Full Text] [Related]
14. An increase in the expression of circulating miR30d-5p and miR126-3p is associated with intermediate hyperglycaemia in Iranian population.
Ghaneh T; Zeinali F; Babini H; Astaraki S; Hassan-Zadeh V
Arch Physiol Biochem; 2023 Apr; 129(2):489-496. PubMed ID: 33113334
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as novel biomarkers for platelet activation.
Willeit P; Zampetaki A; Dudek K; Kaudewitz D; King A; Kirkby NS; Crosby-Nwaobi R; Prokopi M; Drozdov I; Langley SR; Sivaprasad S; Markus HS; Mitchell JA; Warner TD; Kiechl S; Mayr M
Circ Res; 2013 Feb; 112(4):595-600. PubMed ID: 23283721
[TBL] [Abstract][Full Text] [Related]
16. Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y
Braza-Boïls A; Barwari T; Gutmann C; Thomas MR; Judge HM; Joshi A; Pechlaner R; Shankar-Hari M; Ajjan RA; Sabroe I; Storey RF; Mayr M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326325
[TBL] [Abstract][Full Text] [Related]
17. Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus.
Zhou AM; Xiang YJ; Liu EQ; Cai CH; Wu YH; Yang LB; Zeng CL
BMC Cardiovasc Disord; 2020 Jan; 20(1):15. PubMed ID: 31931718
[TBL] [Abstract][Full Text] [Related]
18. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
Cui X; You L; Zhu L; Wang X; Zhou Y; Li Y; Wen J; Xia Y; Wang X; Ji C; Guo X
Metabolism; 2018 Jan; 78():95-105. PubMed ID: 28966078
[TBL] [Abstract][Full Text] [Related]
19. Expression of regulatory platelet microRNAs in patients with sickle cell disease.
Jain S; Kapetanaki MG; Raghavachari N; Woodhouse K; Yu G; Barge S; Coronnello C; Benos PV; Kato GJ; Kaminski N; Gladwin MT
PLoS One; 2013; 8(4):e60932. PubMed ID: 23593351
[TBL] [Abstract][Full Text] [Related]
20. Long-term aerobic exercise training in type two diabetic patients alters the expression of miRNA-223 and its corresponding target, the P2RY12 receptor, attenuating platelet function.
Taghizadeh M; Kargarfard M; Braune S; Jung F; Naderi M
Clin Hemorheol Microcirc; 2022; 80(2):107-116. PubMed ID: 34420942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
